Changes
On July 26, 2022 at 1:16:12 PM UTC, Chimwemwe Mkandawire:
-
No fields were updated. See the metadata diff for more details.
f | 1 | { | f | 1 | { |
2 | "author": "", | 2 | "author": "", | ||
3 | "author_email": "cmkandawire@hivmw.org", | 3 | "author_email": "cmkandawire@hivmw.org", | ||
4 | "creator_user_id": "c64e3919-2d1c-42bf-835b-e85a6be9792c", | 4 | "creator_user_id": "c64e3919-2d1c-42bf-835b-e85a6be9792c", | ||
5 | "groups": [], | 5 | "groups": [], | ||
6 | "id": "a8a53ba8-5318-4827-9add-59567eea2735", | 6 | "id": "a8a53ba8-5318-4827-9add-59567eea2735", | ||
7 | "isopen": false, | 7 | "isopen": false, | ||
8 | "license_id": "notspecified", | 8 | "license_id": "notspecified", | ||
9 | "license_title": "License not specified", | 9 | "license_title": "License not specified", | ||
10 | "maintainer": null, | 10 | "maintainer": null, | ||
11 | "maintainer_email": null, | 11 | "maintainer_email": null, | ||
12 | "metadata_created": "2022-07-26T13:14:45.193308", | 12 | "metadata_created": "2022-07-26T13:14:45.193308", | ||
n | 13 | "metadata_modified": "2022-07-26T13:16:12.208885", | n | 13 | "metadata_modified": "2022-07-26T13:16:12.404027", |
14 | "name": "malawi-integrated-hiv-program-report-2019-q4", | 14 | "name": "malawi-integrated-hiv-program-report-2019-q4", | ||
15 | "notes": "* Scale-up of integrated HIV services had reached the | 15 | "notes": "* Scale-up of integrated HIV services had reached the | ||
16 | following number of sites:\r\n * __763__ static and __168__ | 16 | following number of sites:\r\n * __763__ static and __168__ | ||
17 | outreach HIV testing sites.\r\n * __746__ (static) ART sites; | 17 | outreach HIV testing sites.\r\n * __746__ (static) ART sites; | ||
18 | __623__ of these started at least one pregnant or breastfeeding | 18 | __623__ of these started at least one pregnant or breastfeeding | ||
19 | woman.\r\n * __690__ sites with HIV-exposed children in | 19 | woman.\r\n * __690__ sites with HIV-exposed children in | ||
20 | follow-up.\r\n* __922,473__ persons were tested for HIV and received | 20 | follow-up.\r\n* __922,473__ persons were tested for HIV and received | ||
21 | their results; __182,650 (20%)__ accessed HIV testing for the first | 21 | their results; __182,650 (20%)__ accessed HIV testing for the first | ||
22 | time; __739,823 (80%)__ were repeat testers and __29,606 (4%)__ of | 22 | time; __739,823 (80%)__ were repeat testers and __29,606 (4%)__ of | ||
23 | these received confirmatory testing (after having tested positive in | 23 | these received confirmatory testing (after having tested positive in | ||
24 | the past). __26,276 (2.8%)__ clients received a positive result for | 24 | the past). __26,276 (2.8%)__ clients received a positive result for | ||
25 | the first time1.\r\n* A total of __31,747__ people received __45,411__ | 25 | the first time1.\r\n* A total of __31,747__ people received __45,411__ | ||
26 | self-test kits for either primary or secondary use.\r\n* __21,690 | 26 | self-test kits for either primary or secondary use.\r\n* __21,690 | ||
27 | (87%)__ of 24,778 blood units collected were screened for (at least) | 27 | (87%)__ of 24,778 blood units collected were screened for (at least) | ||
28 | HIV, hepatitis B and syphilis.\r\n* __157,171 (98%)__ of 160,653 women | 28 | HIV, hepatitis B and syphilis.\r\n* __157,171 (98%)__ of 160,653 women | ||
29 | at ANC had their HIV status ascertained; __10,166 (6%)__ of these were | 29 | at ANC had their HIV status ascertained; __10,166 (6%)__ of these were | ||
30 | HIV positive. __144,357 (96%)__ of 150,698 at maternity had their HIV | 30 | HIV positive. __144,357 (96%)__ of 150,698 at maternity had their HIV | ||
31 | status ascertained __10,751 (7%)__ of these were HIV positive.\r\n* | 31 | status ascertained __10,751 (7%)__ of these were HIV positive.\r\n* | ||
32 | __25,354__ patients started ART this quarter; __88%__ were classified | 32 | __25,354__ patients started ART this quarter; __88%__ were classified | ||
33 | as asymptomatic / in WHO stage 1 and started under the \u201cTest & | 33 | as asymptomatic / in WHO stage 1 and started under the \u201cTest & | ||
34 | Treat\u201d policy.\r\n* __833,227__ patients were alive and on ART by | 34 | Treat\u201d policy.\r\n* __833,227__ patients were alive and on ART by | ||
35 | end of December 2019. This means that __78%__ of the estimated | 35 | end of December 2019. This means that __78%__ of the estimated | ||
36 | 1,066,878 HIV positive population was on ART. ART coverage was | 36 | 1,066,878 HIV positive population was on ART. ART coverage was | ||
37 | __74%__ (45,668/ 61,682) for children and __78%__ (787,609 / | 37 | __74%__ (45,668/ 61,682) for children and __78%__ (787,609 / | ||
38 | 1,005,196) for adults.\r\n* __133,377 (93%)__ of viral load results | 38 | 1,005,196) for adults.\r\n* __133,377 (93%)__ of viral load results | ||
39 | from routine monitoring were <1000 copies/ml. Viral suppression rates | 39 | from routine monitoring were <1000 copies/ml. Viral suppression rates | ||
40 | for routine samples among children (0-14 years) and adults (15+ years) | 40 | for routine samples among children (0-14 years) and adults (15+ years) | ||
41 | were __65%__ and __93%__, respectively.\r\n* __72%__ of adults and | 41 | were __65%__ and __93%__, respectively.\r\n* __72%__ of adults and | ||
42 | __75%__ of children were retained alive on ART at 12 months after | 42 | __75%__ of children were retained alive on ART at 12 months after | ||
43 | initiation.5\r\n* Out of __800,994__ patients on first line adult ART | 43 | initiation.5\r\n* Out of __800,994__ patients on first line adult ART | ||
44 | __210,935 (27%)__ were on TDF/3TC/EFV and __554,060 (71%)__ had | 44 | __210,935 (27%)__ were on TDF/3TC/EFV and __554,060 (71%)__ had | ||
45 | transitioned to TDF/3TC/DTG.\r\n* __13,136 6 (>99%)__ of an estimated | 45 | transitioned to TDF/3TC/DTG.\r\n* __13,136 6 (>99%)__ of an estimated | ||
46 | 10,700 3 HIV infected pregnant women in Malawi were on ART this | 46 | 10,700 3 HIV infected pregnant women in Malawi were on ART this | ||
47 | quarter. __10,213 (76%)__ of these were already on ART when getting | 47 | quarter. __10,213 (76%)__ of these were already on ART when getting | ||
48 | pregnant and __2,293 (24%)__ started ART during | 48 | pregnant and __2,293 (24%)__ started ART during | ||
49 | pregnancy/delivery.\r\n* An additional __1,027__ breastfeeding women | 49 | pregnancy/delivery.\r\n* An additional __1,027__ breastfeeding women | ||
50 | started ART in WHO stage 1 or 2. ", | 50 | started ART in WHO stage 1 or 2. ", | ||
51 | "num_resources": 1, | 51 | "num_resources": 1, | ||
52 | "num_tags": 9, | 52 | "num_tags": 9, | ||
53 | "organization": { | 53 | "organization": { | ||
54 | "approval_status": "approved", | 54 | "approval_status": "approved", | ||
55 | "created": "2021-10-14T11:02:35.234558", | 55 | "created": "2021-10-14T11:02:35.234558", | ||
56 | "description": "The Department of HIV & AIDS (DHA) was established | 56 | "description": "The Department of HIV & AIDS (DHA) was established | ||
57 | in 2001, initially as a unit in the Department of Clinical Services, | 57 | in 2001, initially as a unit in the Department of Clinical Services, | ||
58 | to coordinate the biomedical HIV Program in Malawi. The department now | 58 | to coordinate the biomedical HIV Program in Malawi. The department now | ||
59 | carries responsibility for various HIV related programs including: | 59 | carries responsibility for various HIV related programs including: | ||
60 | sexually transmitted infections (STIs), prevention of mother to child | 60 | sexually transmitted infections (STIs), prevention of mother to child | ||
61 | transmission of HIV (PMTCT), and national voluntary male medical | 61 | transmission of HIV (PMTCT), and national voluntary male medical | ||
62 | circumcision program (VMMC). All these HIV program sub-sections are | 62 | circumcision program (VMMC). All these HIV program sub-sections are | ||
63 | linked to one robust monitoring and evaluation sub-section in the HIV | 63 | linked to one robust monitoring and evaluation sub-section in the HIV | ||
64 | and AIDS Department which technically operates under the Central | 64 | and AIDS Department which technically operates under the Central | ||
65 | Monitoring and Evaluation Department (CMED) of the Ministry of | 65 | Monitoring and Evaluation Department (CMED) of the Ministry of | ||
66 | Health.", | 66 | Health.", | ||
67 | "id": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", | 67 | "id": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", | ||
68 | "image_url": | 68 | "image_url": | ||
69 | 2022-04-18-074318.527302WhatsApp-Image-2022-04-18-at-9.42.07-AM.jpeg", | 69 | 2022-04-18-074318.527302WhatsApp-Image-2022-04-18-at-9.42.07-AM.jpeg", | ||
70 | "is_organization": true, | 70 | "is_organization": true, | ||
71 | "name": "dha", | 71 | "name": "dha", | ||
72 | "state": "active", | 72 | "state": "active", | ||
73 | "title": "Department of HIV & AIDS and Viral Hepatitis", | 73 | "title": "Department of HIV & AIDS and Viral Hepatitis", | ||
74 | "type": "organization" | 74 | "type": "organization" | ||
75 | }, | 75 | }, | ||
76 | "owner_org": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", | 76 | "owner_org": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", | ||
77 | "private": false, | 77 | "private": false, | ||
78 | "program_area": "Care and Treatment", | 78 | "program_area": "Care and Treatment", | ||
79 | "relationships_as_object": [], | 79 | "relationships_as_object": [], | ||
80 | "relationships_as_subject": [], | 80 | "relationships_as_subject": [], | ||
81 | "resources": [ | 81 | "resources": [ | ||
82 | { | 82 | { | ||
83 | "cache_last_updated": null, | 83 | "cache_last_updated": null, | ||
84 | "cache_url": null, | 84 | "cache_url": null, | ||
85 | "created": "2022-07-26T13:16:12.244741", | 85 | "created": "2022-07-26T13:16:12.244741", | ||
86 | "description": "Integrated HIV Program Report October-December | 86 | "description": "Integrated HIV Program Report October-December | ||
87 | 2019", | 87 | 2019", | ||
88 | "format": "PDF", | 88 | "format": "PDF", | ||
89 | "hash": "", | 89 | "hash": "", | ||
90 | "id": "d27f6fcb-8bd8-402f-a6ac-9b6a04328b4a", | 90 | "id": "d27f6fcb-8bd8-402f-a6ac-9b6a04328b4a", | ||
91 | "last_modified": "2022-07-26T13:16:12.198853", | 91 | "last_modified": "2022-07-26T13:16:12.198853", | ||
92 | "lfs_prefix": | 92 | "lfs_prefix": | ||
93 | "dha/malawi-integrated-hiv-program-report-2019-q4", | 93 | "dha/malawi-integrated-hiv-program-report-2019-q4", | ||
n | 94 | "metadata_modified": "2022-07-26T13:16:12.213902", | n | 94 | "metadata_modified": "2022-07-26T13:16:12.407876", |
95 | "mimetype": "application/pdf", | 95 | "mimetype": "application/pdf", | ||
96 | "mimetype_inner": null, | 96 | "mimetype_inner": null, | ||
97 | "name": "Malawi Integrated HIV Program Report 2019 Q4", | 97 | "name": "Malawi Integrated HIV Program Report 2019 Q4", | ||
98 | "package_id": "a8a53ba8-5318-4827-9add-59567eea2735", | 98 | "package_id": "a8a53ba8-5318-4827-9add-59567eea2735", | ||
99 | "position": 0, | 99 | "position": 0, | ||
100 | "resource_type": null, | 100 | "resource_type": null, | ||
101 | "sha256": | 101 | "sha256": | ||
102 | "657ad78b3e040c7397bb324cc9b43cb5b9549c3d634a2958ae79741bf4c2011d", | 102 | "657ad78b3e040c7397bb324cc9b43cb5b9549c3d634a2958ae79741bf4c2011d", | ||
103 | "size": 4846218, | 103 | "size": 4846218, | ||
104 | "state": "active", | 104 | "state": "active", | ||
105 | "url": | 105 | "url": | ||
106 | 6a04328b4a/download/malawi_integrated_hiv_program_report_2019-q4.pdf", | 106 | 6a04328b4a/download/malawi_integrated_hiv_program_report_2019-q4.pdf", | ||
107 | "url_type": "upload" | 107 | "url_type": "upload" | ||
108 | } | 108 | } | ||
109 | ], | 109 | ], | ||
t | 110 | "state": "draft", | t | 110 | "state": "active", |
111 | "tags": [ | 111 | "tags": [ | ||
112 | { | 112 | { | ||
113 | "display_name": "anc", | 113 | "display_name": "anc", | ||
114 | "id": "1e47aae6-8e3d-41e7-9b1a-778af0d2f23a", | 114 | "id": "1e47aae6-8e3d-41e7-9b1a-778af0d2f23a", | ||
115 | "name": "anc", | 115 | "name": "anc", | ||
116 | "state": "active", | 116 | "state": "active", | ||
117 | "vocabulary_id": null | 117 | "vocabulary_id": null | ||
118 | }, | 118 | }, | ||
119 | { | 119 | { | ||
120 | "display_name": "art", | 120 | "display_name": "art", | ||
121 | "id": "ab255b9d-6d35-4789-8ce0-ce10bbe1e299", | 121 | "id": "ab255b9d-6d35-4789-8ce0-ce10bbe1e299", | ||
122 | "name": "art", | 122 | "name": "art", | ||
123 | "state": "active", | 123 | "state": "active", | ||
124 | "vocabulary_id": null | 124 | "vocabulary_id": null | ||
125 | }, | 125 | }, | ||
126 | { | 126 | { | ||
127 | "display_name": "blood safety", | 127 | "display_name": "blood safety", | ||
128 | "id": "24fd7907-18be-4ad1-80ad-ba65da6a9707", | 128 | "id": "24fd7907-18be-4ad1-80ad-ba65da6a9707", | ||
129 | "name": "blood safety", | 129 | "name": "blood safety", | ||
130 | "state": "active", | 130 | "state": "active", | ||
131 | "vocabulary_id": null | 131 | "vocabulary_id": null | ||
132 | }, | 132 | }, | ||
133 | { | 133 | { | ||
134 | "display_name": "hiv", | 134 | "display_name": "hiv", | ||
135 | "id": "43013fde-ebf4-470e-9e5d-1a3aa939d404", | 135 | "id": "43013fde-ebf4-470e-9e5d-1a3aa939d404", | ||
136 | "name": "hiv", | 136 | "name": "hiv", | ||
137 | "state": "active", | 137 | "state": "active", | ||
138 | "vocabulary_id": null | 138 | "vocabulary_id": null | ||
139 | }, | 139 | }, | ||
140 | { | 140 | { | ||
141 | "display_name": "htc", | 141 | "display_name": "htc", | ||
142 | "id": "3aafcd8e-f836-4e61-9341-8e298f9d1f3a", | 142 | "id": "3aafcd8e-f836-4e61-9341-8e298f9d1f3a", | ||
143 | "name": "htc", | 143 | "name": "htc", | ||
144 | "state": "active", | 144 | "state": "active", | ||
145 | "vocabulary_id": null | 145 | "vocabulary_id": null | ||
146 | }, | 146 | }, | ||
147 | { | 147 | { | ||
148 | "display_name": "marternity", | 148 | "display_name": "marternity", | ||
149 | "id": "6b01b92e-282f-4812-a909-8fb4b479d0d1", | 149 | "id": "6b01b92e-282f-4812-a909-8fb4b479d0d1", | ||
150 | "name": "marternity", | 150 | "name": "marternity", | ||
151 | "state": "active", | 151 | "state": "active", | ||
152 | "vocabulary_id": null | 152 | "vocabulary_id": null | ||
153 | }, | 153 | }, | ||
154 | { | 154 | { | ||
155 | "display_name": "pmtct", | 155 | "display_name": "pmtct", | ||
156 | "id": "06c11980-f1fe-470d-8791-aeee38a117d5", | 156 | "id": "06c11980-f1fe-470d-8791-aeee38a117d5", | ||
157 | "name": "pmtct", | 157 | "name": "pmtct", | ||
158 | "state": "active", | 158 | "state": "active", | ||
159 | "vocabulary_id": null | 159 | "vocabulary_id": null | ||
160 | }, | 160 | }, | ||
161 | { | 161 | { | ||
162 | "display_name": "report", | 162 | "display_name": "report", | ||
163 | "id": "80c23033-8ff3-483d-8aa6-03e39b117372", | 163 | "id": "80c23033-8ff3-483d-8aa6-03e39b117372", | ||
164 | "name": "report", | 164 | "name": "report", | ||
165 | "state": "active", | 165 | "state": "active", | ||
166 | "vocabulary_id": null | 166 | "vocabulary_id": null | ||
167 | }, | 167 | }, | ||
168 | { | 168 | { | ||
169 | "display_name": "viral load", | 169 | "display_name": "viral load", | ||
170 | "id": "e385a0a4-1722-431f-a657-f9616a14bf6f", | 170 | "id": "e385a0a4-1722-431f-a657-f9616a14bf6f", | ||
171 | "name": "viral load", | 171 | "name": "viral load", | ||
172 | "state": "active", | 172 | "state": "active", | ||
173 | "vocabulary_id": null | 173 | "vocabulary_id": null | ||
174 | } | 174 | } | ||
175 | ], | 175 | ], | ||
176 | "title": "Malawi Integrated HIV Program Report 2019 Q4", | 176 | "title": "Malawi Integrated HIV Program Report 2019 Q4", | ||
177 | "type": "dataset", | 177 | "type": "dataset", | ||
178 | "url": null, | 178 | "url": null, | ||
179 | "version": null, | 179 | "version": null, | ||
180 | "year": "2019" | 180 | "year": "2019" | ||
181 | } | 181 | } |